Skip to main content
SEEGENE, INC. logo

SEEGENE, INC. — Investor Relations & Filings

Ticker · 096530 ISIN · KR7096530001 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2024-03-14 Annual Report
Country KR South Korea
Listing KO 096530

About SEEGENE, INC.

https://www.seegene.com/

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 24th fiscal year (2023) of Seegene, Inc. It contains comprehensive information including company overview, history, capital changes, shareholding status, and governance details. In the South Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K annual report, providing full financial and operational disclosure for the fiscal year. It is not an announcement or a summary, but the full report itself. FY 2023
2024-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Seegene. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the agenda and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2024-03-06 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date'. It explains the company's inability to avoid this date due to internal scheduling constraints. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2024-03-06 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Seegene regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2024-03-06 Korean
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Seegene regarding the determination of a record date for interim/quarterly dividends. It specifies the record date (2024-03-31) and the purpose (determining shareholders for dividends). While it relates to dividends, it is not the final declaration of the dividend amount (which the text explicitly states will be decided later), but rather a procedural notice regarding shareholder records for dividend purposes. This fits the 'Notice of Dividend Amount' (DIV) category as it is the primary regulatory disclosure for dividend-related events.
2024-03-06 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Seegene, dated March 6, 2024. It contains the agenda for the 24th Annual General Meeting, including financial statement approval, director appointments, and remuneration limits. It also includes detailed management reports (business overview, industry status, and governance information) as required by Korean commercial law for such notices. Since this document serves as the official notice and information package for the upcoming AGM, it is classified as AGM-R.
2024-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.